Advent International, L.P.
+21.04%
3M Return
$26.870
+0.583 (+2.17%)At close
Waystar Holding Corp. provides healthcare organizations with mission-critical cloud software that simplifies healthcare payments. The Company’s enterprise-grade platform, Waystar, streamlines the complex processes. It leverages internally developed artificial intelligence (AI) as well as proprietary, advanced algorithms to automate payment-related workflow tasks and drive continuous improvement, which enhances claim and billing accuracy, enriches data integrity, and reduces labor costs for providers. Its software is used daily by providers of all types and sizes across the continuum of care, including physician practices, clinics, surgical centers, and laboratories, as well as large hospitals and health systems. The Company’s clients utilize its software to manage pre-encounter workflows, such as eligibility checks and prior authorization approvals, as well as mid- and post-encounter workflows, such as co-pay collection, claims submission and monitoring, and payer remittances.
Waystar Holding Corp is a good buy right now due to its current price of $26.68, which is below several analyst price targets, including $28 from Citi and $44 from RBC. The company has shown strong revenue growth of 18% year-over-year in Q2 2026, and its forward P/E ratio of 12.80 indicates it is potentially undervalued compared to its growth prospects. However, a risk to consider is the insider selling activity, which has increased by 280.05% over the last month, indicating potential concerns from insiders about the company's future performance.

Waystar to Report Q3 Financial Results on November 2, 2026

Chipmakers' Stocks Rebound Amid Market Volatility

Waystar Explores Potential Sale, RBC Maintains Outperform Rating
Waystar Unveils AltitudeAI Innovations to Enhance Healthcare Revenue Management

Waystar Unveils AltitudeAI Innovations to Enhance Revenue Cycle
Waystar Holding Corp. provides healthcare organizations with mission-critical cloud software that simplifies healthcare payments. The Company’s enterprise-grade platform, Waystar, streamlines the complex processes. It leverages internally developed artificial intelligence (AI) as well as proprietary, advanced algorithms to automate payment-related workflow tasks and drive continuous improvement, which enhances claim and billing accuracy, enriches data integrity, and reduces labor costs for providers. Its software is used daily by providers of all types and sizes across the continuum of care, including physician practices, clinics, surgical centers, and laboratories, as well as large hospitals and health systems. The Company’s clients utilize its software to manage pre-encounter workflows, such as eligibility checks and prior authorization approvals, as well as mid- and post-encounter workflows, such as co-pay collection, claims submission and monitoring, and payer remittances. It operates in the Technology sector (COMPUTER INTEGRATED SYSTEMS DESIGN industry).
Waystar Holding Corp is a good buy right now due to its current price of $26.68, which is below several analyst price targets, including $28 from Citi and $44 from RBC. The company has shown strong revenue growth of 18% year-over-year in Q2 2026, and its forward P/E ratio of 12.80 indicates it is potentially undervalued compared to its growth prospects. However, a risk to consider is the insider selling activity, which has increased by 280.05% over the last month, indicating potential concerns from insiders about the company's future performance.
No posts yet
Sign up or log in to join the discussionThis page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.